JP2025118775A5 - - Google Patents

Info

Publication number
JP2025118775A5
JP2025118775A5 JP2025076816A JP2025076816A JP2025118775A5 JP 2025118775 A5 JP2025118775 A5 JP 2025118775A5 JP 2025076816 A JP2025076816 A JP 2025076816A JP 2025076816 A JP2025076816 A JP 2025076816A JP 2025118775 A5 JP2025118775 A5 JP 2025118775A5
Authority
JP
Japan
Prior art keywords
formula
linker
pharmaceutically acceptable
pharmaceutical composition
radical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2025076816A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025118775A (ja
Filing date
Publication date
Priority claimed from JP2022541787A external-priority patent/JP7678813B2/ja
Application filed filed Critical
Publication of JP2025118775A publication Critical patent/JP2025118775A/ja
Publication of JP2025118775A5 publication Critical patent/JP2025118775A5/ja
Pending legal-status Critical Current

Links

JP2025076816A 2020-01-07 2025-05-02 標的指向性ステロイド化合物 Pending JP2025118775A (ja)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US202062958102P 2020-01-07 2020-01-07
US62/958,102 2020-01-07
US202063030020P 2020-05-26 2020-05-26
US63/030,020 2020-05-26
JP2022541787A JP7678813B2 (ja) 2020-01-07 2021-01-07 標的指向性ステロイド化合物
PCT/US2021/012532 WO2021142145A1 (en) 2020-01-07 2021-01-07 Targeted steroid conjugates

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2022541787A Division JP7678813B2 (ja) 2020-01-07 2021-01-07 標的指向性ステロイド化合物

Publications (2)

Publication Number Publication Date
JP2025118775A JP2025118775A (ja) 2025-08-13
JP2025118775A5 true JP2025118775A5 (cg-RX-API-DMAC7.html) 2026-03-19

Family

ID=76787625

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022541787A Active JP7678813B2 (ja) 2020-01-07 2021-01-07 標的指向性ステロイド化合物
JP2025076816A Pending JP2025118775A (ja) 2020-01-07 2025-05-02 標的指向性ステロイド化合物

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2022541787A Active JP7678813B2 (ja) 2020-01-07 2021-01-07 標的指向性ステロイド化合物

Country Status (11)

Country Link
US (1) US20230331767A1 (cg-RX-API-DMAC7.html)
EP (1) EP4087580A4 (cg-RX-API-DMAC7.html)
JP (2) JP7678813B2 (cg-RX-API-DMAC7.html)
KR (1) KR20220124742A (cg-RX-API-DMAC7.html)
CN (1) CN115003308A (cg-RX-API-DMAC7.html)
AU (1) AU2021205255A1 (cg-RX-API-DMAC7.html)
BR (1) BR112022013478A2 (cg-RX-API-DMAC7.html)
CA (1) CA3163268A1 (cg-RX-API-DMAC7.html)
IL (2) IL326516A (cg-RX-API-DMAC7.html)
MX (1) MX2022008343A (cg-RX-API-DMAC7.html)
WO (1) WO2021142145A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115232186B (zh) * 2022-07-07 2024-03-01 武汉工程大学 一种泼尼松磷酸酯及其盐的制备方法和应用
WO2024025845A1 (en) * 2022-07-25 2024-02-01 Sorrento Therapeutics, Inc. Folate-conjugated drugs and uses thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6379698B1 (en) * 1999-04-06 2002-04-30 Isis Pharmaceuticals, Inc. Fusogenic lipids and vesicles
AU2003216445A1 (en) * 2002-02-27 2003-09-09 The Medical College Of Ohio Therapeutic methods for acute myeloid leukemia
JP5175723B2 (ja) 2005-07-05 2013-04-03 パーデュー・リサーチ・ファウンデーション 単球介在性疾患を治療するための組成物の調製
WO2007139815A2 (en) 2006-05-23 2007-12-06 Purdue Research Foundation Imaging and therapeutic method using progenitor cells
US8507455B2 (en) * 2007-12-04 2013-08-13 Alnylam Pharmaceuticals, Inc. Folate conjugates
WO2011150392A1 (en) * 2010-05-28 2011-12-01 Purdue Research Foundation Delivery of therapeutic agents to inflamed tissues using folate-targeted agents
EA201590622A1 (ru) 2012-10-16 2015-10-30 Эндосайт, Инк. Конъюгаты для доставки лекарственного средства, содержащие не встречающиеся в природе аминокислоты, и способы применения
HK1259487A1 (zh) * 2016-02-04 2019-11-29 Hangzhou Dac Biotech Co. Ltd. 特定的共轭连接子,特定的免疫共轭物,制造和使用这些共轭物的方法
WO2018045245A1 (en) * 2016-09-02 2018-03-08 Sirenas Llc Cyclic peptide analogs and conjugates thereof
KR20220147719A (ko) * 2016-11-14 2022-11-03 항저우 디에이씨 바이오테크 씨오, 엘티디 결합 링커, 그러한 결합 링커를 함유하는 세포 결합 분자-약물 결합체, 링커를 갖는 그러한 결합체의 제조 및 사용
AU2020279979A1 (en) * 2019-05-20 2021-11-25 Les Laboratoires Servier Mcl-1 inhibitor antibody-drug conjugates and methods of use

Similar Documents

Publication Publication Date Title
JP2021063088A5 (cg-RX-API-DMAC7.html)
JP2025116875A5 (cg-RX-API-DMAC7.html)
JP2021100937A5 (cg-RX-API-DMAC7.html)
JP2023002662A5 (cg-RX-API-DMAC7.html)
CN113365998A (zh) 用于parp抑制剂的吲哚并七元酰肟类似物
JP2020189864A5 (cg-RX-API-DMAC7.html)
JP2006182786A5 (cg-RX-API-DMAC7.html)
JP2008501705A5 (cg-RX-API-DMAC7.html)
JP2020507589A5 (cg-RX-API-DMAC7.html)
JP2024540183A5 (cg-RX-API-DMAC7.html)
JP2023543059A5 (cg-RX-API-DMAC7.html)
JP2003507438A5 (cg-RX-API-DMAC7.html)
JP2023506691A5 (cg-RX-API-DMAC7.html)
JP2022553954A5 (cg-RX-API-DMAC7.html)
JP2010522756A5 (cg-RX-API-DMAC7.html)
CN110612143B (zh) 抗微生物化合物、组合物及其用途
JP2011505356A5 (cg-RX-API-DMAC7.html)
JP2022527401A5 (cg-RX-API-DMAC7.html)
JP2021534160A5 (cg-RX-API-DMAC7.html)
JP2003519228A5 (cg-RX-API-DMAC7.html)
JP2006506345A5 (cg-RX-API-DMAC7.html)
JP2017522304A5 (cg-RX-API-DMAC7.html)
WO2014129495A1 (ja) 眼疾患処置薬
JP2010505865A5 (cg-RX-API-DMAC7.html)
JP2023537921A5 (cg-RX-API-DMAC7.html)